Arrr! The FDA be eyein’ AstraZeneca's NSCLC trial like a parrot on a treasure map—questionin’ their course, savvy?
2024-07-29
Arrr, matey! The scallywags at the agency be sayin' there's a right pickle with the latest potion for lung troubles! After surgery, ye can't tell if ye should keep takin' the magic elixir or toss it overboard. Blimey, we be needin' a proper map for this treasure!
Ahoy, mateys! Gather 'round as I spin ye a yarn 'bout the latest shenanigans in the realm o' medicine, where the landlubbers at the agency be all in a tangle 'bout the trial of that fancy newfangled perioperative immunotherapy for the cursed beast known as NSCLC. Aye, it seems they’ve run aground on a problem most vexin’—they be clueless as to whether the poor souls need to keep swiggin' their potions after they’ve had their surgery! Arrr!